Photoacoustic device promising for routine breast cancer screening

Recognizing that routine screening can increase breast cancer survival by detecting the disease early, a team of researchers at the University of Twente (Enschede, The Netherlands) have developed an imaging tool prototype that may one day help to detect breast cancer early—when it is most treatable.

Related: Bioimaging combo approach captures live images of growing tumors

Related: Raman spectroscopy algorithm could better detect breast cancer

If effective, the new device, dubbed a photoacoustic mammoscope, would represent an entirely new way of imaging the breast and detecting cancer. Instead of x-rays, which are used in traditional mammography, the photoacoustic breast mammoscope uses a combination of infrared (IR) light and ultrasound to create a 3D map of the breast.

A schematic illustration of the imaging system and the ultrasound detector
A schematic illustration of the imaging system and the ultrasound detector. (Image courtesy of Wenfeng Xia, Biomedical Photonic Imaging group, University of Twente)

With the mammoscope, IR light is delivered in billionth-of-a-second pulses to tissue, where it is scattered and absorbed. The high absorption of blood increases the temperature of blood vessels slightly, and this causes them to undergo a slight but rapid expansion. While imperceptible to the patient, this expansion generates detectable ultrasound waves that are used to form a 3D map of the breast vasculature. Since cancer tumors have more blood vessels than the surrounding tissue, they are distinguishable in this image.

Currently, the resolution of the images is not as fine as what can be obtained with existing breast imaging techniques like x-ray mammography and MRI. In future versions, Srirang Manohar, an assistant professor at the University of Twente who led the research; Wenfeng Xia, a graduate student at the University of Twente who is the first author on the new paper; and their colleagues expect to improve the resolution as well as add the capability to image using several different wavelengths of light at once, which is expected to improve detectability.

A top (a) and side (b) view of a 3D-reconstructed phantom object made of gels and other materials that mimic human tissue. The background of this phantom mimics normal breast tissue, while several objects embedded within the material mimic blood vessels and tumors. Two slices of images (c and d) of a reconstructed phantom taken with the new device. The location of five objects are indicated with arrows: objects 1 and 2 mimic blood vessels, while objects 3-5 mimic tumors
A top (a) and side (b) view of a 3D-reconstructed phantom object made of gels and other materials that mimic human tissue. The background of this phantom mimics normal breast tissue, while several objects embedded within the material mimic blood vessels and tumors. Two slices of images (c and d) of a reconstructed phantom taken with the new device. The location of five objects are indicated with arrows: objects 1 and 2 mimic blood vessels, while objects 3-5 mimic tumors. (Image courtesy of Wenfeng Xia, Biomedical Photonic Imaging group, University of Twente)

The researchers, who belong to the Biomedical Photonic Imaging group run by Prof. Wiendelt Steenbergen, have tested their prototype in the laboratory using phantoms—objects made of gels and other materials that mimic human tissue. Last year, in a small clinical trial they showed that an earlier version of the technology could successfully image breast cancer in women.

Manohar and his colleagues added that if the instrument were commercialized, it would likely cost less than MRI and x-ray mammography.

"We feel that the cost could be brought down to be not much more expensive than an ultrasound machine when it goes to industry," says Xia.

The next step, they say, will be to prepare for larger clinical trials. Several existing technologies are already widely used for breast cancer screening and diagnosis, including mammography, MRI, and ultrasound. Before becoming routinely used, the photoacoustic mammoscope would have to prove at least as effective as those other techniques in large, multicenter clinical trials.

"We are developing a clinical prototype that improves various aspects of the current version of the device,” said Manohar. "The final prototype will be ready for first clinical testing next year."

Full details of the work appear in the journal Biomedical Optics Express; for more information, please visit http://www.opticsinfobase.org/boe/abstract.cfm?URI=boe-4-11-2555.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

POST A COMMENT

Related Articles

Label-free optical biosensor can detect rotavirus

Researchers at the Universidad Politécnica de Madrid (UPM) in Spain, using a label-free optical biosensor they developed, have found a way to enhance detection capacity of small concentrations of r...
Synthetic, blue light-sensitive molecular switches can be utilized to control biochemical signaling processes in living cells

Blue LED light enables control of insulin secretion

An international team of researchers has incorporated a synthetic, blue light-sensitive molecular switch into a sulfonylurea compound—a class of drugs widely used to regulate blood glucose levels i...

Abbott, Carl Zeiss Meditec enter distribution agreement for laser cataract surgery product portfolio

Abbott Medical Optics (Santa Ana, CA) and Carl Zeiss Meditec (Jena, Germany) have entered into a nonexclusive agreement in which Abbott will offer each company's suite of laser cataract surgery pro...

Photodynamic therapy for deep cancer cells could get a boost with new nanoparticle

An international team of researchers has combined a new type of nanoparticle with an FDA-approved photodynamic therapy (PDT) to effectively kill deep-set cancer cells in vivo with minimal damage to...

BLOGS

Optogenetics among photonics techniques highlighted at Neuroscience 2014

Optogenetics among photonics techniques highlighted at Neuroscience 2014

Technology in general, and optogenetics in particular, is a focus here at Neuroscience 2015, wher...
BioOptics World editor-in-chief Barbara Goode

What is biophotonics?

At BioOptics World, our focus is photonics (including optics) for life sciences—that is, biophoto...

Nobel Prize honors super-resolution optical microscopy

"This year's prize is about how the optical microscope became a nanoscope," said Staffa...

Most Popular Articles


CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2014. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS